A retrospective study of characteristics of pediatric patients with residual weakness as evidenced by re-dosing Sugammadex
Latest Information Update: 06 Dec 2021
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 06 Dec 2021 New trial record
- 12 Oct 2021 Results presented at the ANESTHESIOLOGY 2021 Annual Meeting of the American Society of Anesthesiologists